June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Antimetabolite augmented slit-lamp needling for the management of post-trabeculectomy failing bleb.
Author Affiliations & Notes
  • Montserrat Romo Sainz
    Instituto de Oftalmología y Ciencias Visuales, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico
  • Jose A Paczka
    Instituto de Oftalmología y Ciencias Visuales, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico
    Research & Development, Unidad de Diagnóstico Temprano del Glaucoma, Guadalajara, Mexico
  • Yesenia Yolanda Dorantes Diez
    Instituto de Oftalmología y Ciencias Visuales, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico
  • Luz America Giorgi Sandoval
    Research & Development, Unidad de Diagnóstico Temprano del Glaucoma, Guadalajara, Mexico
  • Monica Montserrat M Gonzalez Lomeli
    Research & Development, Unidad de Diagnóstico Temprano del Glaucoma, Guadalajara, Mexico
  • Karla J Aguilera Ruiz
    Oftalmología, Instituto Mexicano del Seguro Social, Guadalajara, Mexico
  • Andrea Orozco Garcia
    Oftalmología, Antiguo Hospital Civil de Guadalajara, Guadalajara, Mexico
  • Footnotes
    Commercial Relationships   Montserrat Romo Sainz, None; Jose Paczka, None; Yesenia Dorantes Diez, None; Luz Giorgi Sandoval, None; Monica Montserrat Gonzalez Lomeli, None; Karla J Aguilera Ruiz, None; Andrea Orozco Garcia, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 4943. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Montserrat Romo Sainz, Jose A Paczka, Yesenia Yolanda Dorantes Diez, Luz America Giorgi Sandoval, Monica Montserrat M Gonzalez Lomeli, Karla J Aguilera Ruiz, Andrea Orozco Garcia; Antimetabolite augmented slit-lamp needling for the management of post-trabeculectomy failing bleb.. Invest. Ophthalmol. Vis. Sci. 2017;58(8):4943.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To evaluate efficacy and safety of 5 fluorouracil (5-FU) or mitomycin C (MMC) augmented slit-lamp needling to manage post-trabeculectomy failing blebs in a cohort of Latino patients affected by diverse types of glaucoma.

Methods : Four hundred seventeen consecutive cases of trabeculectomy supplemented with intra-operative mitomycin C (MMC) with at least one year follow-up were retrospectively assessed. A total of 75 cases underwent either 5-FU (250 mcg / 0.1ml) or MMC (0.25 mg / 0.1 ml) augmented bleb needling in at least one eye. Major outcome variables were mean decrease of IOP, number of antiglaucoma medications, success rate and presence of complications.

Results : Intraocular pressure decreased from 19.9 ± 5.8 mm Hg (5-FU group) and 20.2 ± 5.1 mm Hg (MMC group) to 15.3 ± 3.6 mm Hg (P = 0.001) and 13.9 ± 3.2 mm Hg (P = 0.001), respectively, at 12 months. Antiglaucoma medications decreased from 2.2 ± 0.8 (5-FU) and 2.5 ± 0.9 (MMC) to 1.8 ± 0.4 (P = 0.0001) and 1.1 ± 0.3 (P = 0.0001), respectively, at 12 months. Global success rate was 72.1% (5FU) and 81.2% (MMC) (P = 0.042), at 12 months. Most common complication was persistent hypotony, presented in 4.7% of the 5-FU group and in the 12.5% of MMC group (P = 0.02).

Conclusions : Antimetabolite augmented slit-lamp needle revision confirms to be an effective and safe option to treat post-trabeculectomy failing blebs in a cohort of Latino patients. MMC might be more effective than 5-FU, although with higher risk of persistent hypotony.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×